Home > > > Livestock mRNA Vaccines Market Size to Reach USD 28.4 Million by 2032 | CAGR 11.0% | Growth & Foreca

Livestock mRNA Vaccines Market Size to Reach USD 28.4 Million by 2032 | CAGR 11.0% | Growth & Foreca

Author : shivani ghodake | Published On : 22 Sep 2026

According to a report by Intel Market Research, global Livestock mRNA Vaccines Market was valued at USD 13.8 million in 2024 and is projected to grow from USD 15.3 million in 2025 to USD 28.4 million by 2032, registering a CAGR of 11.0% during the forecast period. The report analyzes market size, share, growth, forecast, vaccine type, livestock applications, regional opportunities and competitive dynamics. North America currently leads the market, while Asia-Pacific is expected to record the fastest growth.

Explore the full report: https://www.intelmarketresearch.com/global-livestock-mrna-vaccines-forecast-2025-2032-424-2683

Download FREE Sample Report: https://www.intelmarketresearch.com/download-free-sample/2683/livestock-mrna-vaccines

Market Drivers

 

  • Rising Livestock Disease Prevalence — Persistent infectious-disease risks are increasing demand for innovative veterinary vaccination technologies.
  • Rapid Vaccine Development Potential — mRNA technology offers a platform capable of supporting faster development for emerging livestock diseases.
  • Growing Animal Health Investment — Government initiatives and increasing focus on livestock health are supporting development of advanced veterinary vaccines.

 

Vertical Industry Watch

The livestock mRNA vaccines market is emerging as an advanced segment of veterinary biotechnology. mRNA platforms provide genetic instructions that stimulate an immune response without requiring exposure to the actual pathogen, creating opportunities for rapid vaccine development. The technology is gaining attention as livestock producers and veterinary organizations seek improved approaches to infectious disease management. Research and commercialization efforts cover cattle, pigs and other livestock categories, while vaccine administration methods include injectable and non-invasive approaches. North America currently holds the leading market position, supported by established animal-health infrastructure and research capabilities. Asia-Pacific is expected to grow rapidly through 2032, supported by China's expanding livestock industry and increasing attention to animal health.

Download FREE Sample Report: https://www.intelmarketresearch.com/download-free-sample/2683/livestock-mrna-vaccines

Market Segmentation

By Type

 

  • Injectable Drug Administration
  • Non-invasive Drug Administration

 

By Application

 

  • Cattle
  • Pigs
  • Others

 

Regional Outlook

North America currently leads the livestock mRNA vaccines market with a 38% share in 2024, supported by established veterinary infrastructure, research capabilities and animal-health investment.

Asia-Pacific is expected to be the fastest-growing regional market through 2032, with China representing an important market because of its large livestock industry. Europe also provides opportunities through established animal-health systems and biotechnology capabilities. Latin America and other livestock-producing regions represent additional opportunities as disease prevention and productivity become increasingly important.

Download FREE Sample Report: https://www.intelmarketresearch.com/download-free-sample/2683/livestock-mrna-vaccines

Why This Market Matters

Livestock mRNA vaccines represent an emerging biotechnology platform with potential implications for disease prevention, livestock productivity and veterinary medicine. The market creates opportunities for vaccine developers, animal-health companies, biotechnology firms and research organizations. Rapid development capabilities can be particularly relevant when responding to emerging infectious diseases. Understanding vaccine administration methods and livestock applications can help stakeholders evaluate development priorities and commercial opportunities. Regional analysis also provides insight into markets where livestock populations, animal-health infrastructure and government support can influence adoption.

Competitive Landscape

 

  • Ceva Animal Health — Participates in the animal-health market with vaccines and veterinary healthcare solutions.
  • Merck Animal Health — Provides veterinary vaccines and animal-health products across livestock markets.
  • Bayer — Operates across animal health and life sciences, supporting veterinary healthcare applications.
  • BioNTech — Brings mRNA platform expertise relevant to next-generation vaccine development.
  • Genvax Technologies — Focuses on mRNA vaccine technologies for animal-health applications.

 

View the full report: https://www.intelmarketresearch.com/global-livestock-mrna-vaccines-forecast-2025-2032-424-2683

Frequently Asked Questions

1. What is the Livestock mRNA Vaccines Market size? The market was valued at USD 13.8 million in 2024 and is projected to reach USD 28.4 million by 2032 at a CAGR of 11.0%.

2. Which livestock applications are covered? The report covers Cattle, Pigs and Others.

3. Which region currently leads the market? North America currently leads the market, while Asia-Pacific is expected to be the fastest-growing region through 2032.

What Does the Full Report Cover?

The full Intel Market Research report provides a comprehensive assessment of the global Livestock mRNA Vaccines Market, covering historical market size, forecast growth, vaccine administration types, livestock applications, regional performance and competitive dynamics. The study evaluates the role of mRNA technology in veterinary medicine and examines factors supporting development, including livestock disease prevalence, vaccine-development advantages, meat consumption and government animal-health initiatives. Key companies are profiled to provide insight into the competitive environment. The report supports animal-health companies, biotechnology developers, vaccine manufacturers, investors, veterinary organizations and strategic decision-makers evaluating emerging opportunities in livestock vaccination.

Download FREE Sample Report: https://www.intelmarketresearch.com/download-free-sample/2683/livestock-mrna-vaccines

Access the complete report: https://www.intelmarketresearch.com/global-livestock-mrna-vaccines-forecast-2025-2032-424-2683

Related Reports

 

 

About Intel Market Research

Intel Market Research provides market intelligence across technology, software, artificial intelligence, cloud computing, industrial technology and other sectors. Its reports cover market sizing, forecasting, segmentation, regional analysis, technology trends and competitive developments.

Contact Details

Website: www.intelmarketresearch.com | Asia-Pacific: +91 9169164321